This is a prospective, Open-label, comparative clinical study to asses two brilliant blue G dyes as staining agent in Vitro Retinal Surgery.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Staining Ability of ILM
Timeframe: Intra-Operatively
Change from Baseline to 1 Month, 3 Months and 6 Months in CMT (Central Macular Thickness)
Timeframe: Pre-Op, 1 Month, 3 Month and 6 Month
Change from Baseline to 1 Month, 3 Months and 6 Months in TMV ( Total Macular Volume)
Timeframe: Pre-Op, 1 Month, 3 Month and 6 Month
Change from Baseline to 1 Month, 3 Months and 6 Months in SFCT (sub foveal choroidal thickness)
Timeframe: Pre-Op, 1 Month, 3 Month and 6 Month
Change from Baseline to 1 Month, 3 Months and 6 Months in Intra-retinal cuff pathology segmentation
Timeframe: Pre-Op, 1 Month, 3 Month and 6 Month
Change from Baseline to 1 Month, 3 Months and 6 Months in RNFL Thickness (Retinal Nerve Fiber Layer)
Timeframe: Pre-Op, 1 Month, 3 Month and 6 Month
Change from Baseline to 1 Month, 3 Months and 6 Months in Hole diameter
Timeframe: Pre-Op, 1 Month, 3 Month and 6 Month
Change from Baseline to 1 Month, 3 Months and 6 Months in Optic Disc situation
Timeframe: Pre-Op, 1 Month, 3 Month and 6 Month
Change from Baseline to 6 Month in Foveal perfusion characteristics
Timeframe: Pre-Op, 6 Month
Change from Baseline to 6 Month in Vascular evaluation
Timeframe: Pre-Op, 6 Month
Change from Baseline to 6 Month in Fundus auto fluorescence (FAF)
Timeframe: Pre-Op, 6 Month
Multifocal ERG
Timeframe: Pre-op, 1 Month, 3 Month and 6 Month
Overview of Adverse Events
Timeframe: Through study completion, an average of 6 Months